Sringa Life Sciences began in India with a single objective: give the global pharmaceutical industry a dependable source of key starting materials (KSMs), Active Pharmaceutical Ingredient (API) intermediates and impurity synthesis services, at agreed cost and on an agreed schedule.
Our scope reaches from early-stage research through scale-up and manufacture, covering KSMs, API intermediates and a carefully built library of synthesised impurity standards. The approach is deliberately plain: work out what a customer genuinely needs, then supply both the chemistry and the data that stands behind it.
Talk to UsComplete development and manufacture of the starting materials and intermediates that make multi-step API synthesis possible, produced in line with ICH Q7 GMP guidance.
High-purity compounds built to your brief, from milligram research samples through to tonne-scale supply, with route optimisation and GMP-aligned scale-up included.
A full process improvement and technology transfer service that moves your chemistry out of research and into commercial manufacture, efficiently and within regulatory limits.
Focused synthesis, isolation and purification of API impurities: process, degradation, genotoxic (GTI), nitrosamine and metabolite standards, each supplied with ICH-aligned characterisation.
Methodical QC by ¹H-NMR, HPLC, LC-MS and Karl Fischer, with a complete Certificate of Analysis (CoA) travelling with every compound.
Everything we despatch is prepared to ICH guidelines, so it drops straight into stability studies, method validation and impurity profiling for submissions in any market.
To give the pharmaceutical industry a dependable source of API intermediates, specialty chemicals and impurity synthesis — at agreed cost, on agreed dates. That starts with understanding precisely what a customer requires, then meeting it with products and service they can plan around.
To become a globally trusted and sustainable partner in healthcare, recognised for inventive, well-priced chemistry that quietly improves lives. We reach that by continuing to develop and manufacture safe, novel and affordable pharmaceuticals over the long term.
Quality here is not a framed certificate. It is a working set of operating rules, and every chemist, every analyst and every despatch is measured against them.